CT评估肌肉质量与肌肉脂肪变性的方法学系统综述
该研究系统检索了PubMed 1983至2017年的文献,纳入388项使用CT测量肌肉质量或肌肉脂肪变性的研究,发现CT协议在解剖标志、阈值、分割肌肉、关键测量指标等方面差异很大,且多数研究未报告静脉造影和层厚等关键参数,呼吁建立CT评估肌少症与肌肉脂肪变性的共识。
要点
- CT评估肌肉质量比肌肉脂肪变性更常用(330项 vs 125项)。
- 腹部最常用L3椎体为标志,常用指标为骨骼肌指数和肌间脂肪组织。
- 多数研究未报告静脉造影(94%)和层厚(63%)等CT技术参数。
核心结论
- CT评估肌肉质量和肌肉脂肪变性的方法差异很大,亟需建立共识。
研究设计与样本
- 系统综述,检索PubMed 1983至2017年文献,657篇文献中388项研究符合纳入标准。
主要发现
- 肌肉质量评估(330项)比肌肉脂肪变性(125项)更常见。
- 最常评估的肌肉群为全腹壁肌肉(肌肉质量142/330,肌肉脂肪变性49/125)和全大腿肌肉(90/330和48/125)。
- 腹部最常用标志为L3椎体(肌肉质量123/142,肌肉脂肪变性45/49)。
- 腹壁肌肉质量最常用指标为骨骼肌指数(114/142),肌肉脂肪变性最常用指标为肌间脂肪组织(27/49)。
- 各研究截点值存在差异,94%和63%的研究分别未报告静脉造影和层厚。
关键数值与推荐
- 原文未报告统一的CT评估标准或推荐条款。
临床怎么用
- 临床采用CT评估肌少症时需注意不同研究方法的异质性,并应完整报告技术参数。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/OBJECTIVE: There is increasing use of computed tomography (CT) in sarcopenia research using a wide variety of techniques. We performed a systematic review of the CT literature to identify the differences between approaches used. METHODS: A comprehensive search of PubMed from 1983 to 2017 was performed to identify studies that used CT muscle measurements to assess muscle mass and myosteatosis. The CT protocols were evaluated based on anatomic landmark(s), thresholding, muscle(s) segmented, key measurement (ie, muscle attenuation, cross-sectional area, volume), derived variables, and analysis software. From the described search, 657 articles were identified and 388 studies met inclusion criteria for this systematic review. RESULTS: Muscle mass was more commonly assessed than myosteatosis (330 vs. 125). The most commonly assessed muscle or muscle groups were total abdominal wall musculature (142/330 and 49/125 for muscle mass and myosteatosis, respectively) and total thigh musculature (90/330 and 48/125). The most commonly used landmark in the abdomen was the L3 vertebra (123/142 and 45/49 for muscle mass and myosteatosis, respectively). Skeletal muscle index and intermuscular adipose tissue were the most commonly used measures of abdominal wall muscle mass (114/142) and myosteatosis (27/49), respectively. Cut points varied across studies. A significant majority of studies failed to report important CT technical parameters, such as use of intravenous contrast and slice thickness (94% and 63%, respectively). CONCLUSIONS: There is considerable variation in the CT approaches used for the assessment of muscle mass and myosteatosis. There is a need to develop consensus for CT-based evaluation of sarcopenia and myosteatosis.
引用
- Amini B, Boyle SP, Boutin RD, et al. Approaches to Assessment of Muscle Mass and Myosteatosis on Computed Tomography: A Systematic Review. J Gerontol A Biol Sci Med Sci. 2019. PMID: 30726878. doi:10.1093/gerona/glz034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。